Thoughts on this? >> Bristol Myers' cancer drug Augtyro wins new accelerated approval in solid tumors >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #pharmaceutical #productmarketing #healthcare
LucidQuest的动态
最相关的动态
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Bristol Myers' cancer drug Augtyro wins new accelerated approval in solid tumors >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #productmarketing
Bristol Myers' cancer drug Augtyro wins new accelerated approval in solid tumors
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> #ESMO24: Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #biotech #pharmaceutical
Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #pharma #biotech #healthcare
FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit
endpts.com
-
Thoughts on this? >> #ESMO24: Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Gilead’s blockbuster ADC Trodelvy fails bladder cancer confirmatory study >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #pharma #productmarketing
Gilead’s blockbuster ADC Trodelvy fails bladder cancer confirmatory study
endpts.com
-
Thoughts on this? >> FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #biotech #healthcare #pharmaceutical
FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit
endpts.com
-
Thoughts on this? >> Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #productmarketing #pharma
FDA approves Servier’s targeted brain cancer drug
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical
FDA approves Servier’s targeted brain cancer drug
endpts.com
-
Thoughts on this? >> Gilead’s blockbuster ADC Trodelvy fails bladder cancer confirmatory study >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #productmarketing
Gilead’s blockbuster ADC Trodelvy fails bladder cancer confirmatory study
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Ideaya outlines regulatory path for rare eye cancer drug after positive mid-stage data >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #healthcare #productmarketing
Ideaya outlines regulatory path for rare eye cancer drug after positive mid-stage data
endpts.com
